WallStSmart
BDTX

Black Diamond Therapeutics Inc

NASDAQ: BDTX · HEALTHCARE · BIOTECHNOLOGY

$2.65
+3.11% today

Updated 2026-04-30

Market cap
$170.15M
P/E ratio
7.62
P/S ratio
2.43x
EPS (TTM)
$0.39
Dividend yield
52W range
$1 – $5
Volume
0.7M

Black Diamond Therapeutics Inc (BDTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+70.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+51.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.6%
2026-03-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-18$-0.14+22.1%$2.23$2.15-3.6%
2025-11-06$-0.15+36.2%$3.87$3.89+0.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.17$-0.14+22.1%
2025-09-30$-0.24$-0.15+36.2%
2025-06-30$-0.25$-0.19+23.0%
2025-03-31$-0.26$0.98+484.3%$70.00M
2024-12-31$-0.31$-0.28+10.2%$516000.00-89.5%
2024-09-30$-0.37$-0.28+25.6%
2024-06-30$-0.39$-0.36+7.7%
2024-03-31$-0.43$-0.35+18.6%
2023-12-31$-0.47$-0.34+27.7%$4.89M
2023-09-30$-0.49$-0.45+8.2%
2023-06-30$-0.54$-0.52+3.7%
2023-03-31$-0.61$-0.57+6.6%

Frequently asked questions

Has Black Diamond Therapeutics Inc beaten earnings estimates?
Black Diamond Therapeutics Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +70.3% over the last 4 quarters.
How does BDTX stock react to earnings?
BDTX stock has moved an average of -1.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.